Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites

Biomedical Chromatography

Volumn 26, Issue 1, 2012, Pages 89-94

  Mattarucchi, Elia ^a   Baraldi, Eugenio ^b   Guillou, Claude ^a  

^a JOINT RESEARCH CENTRE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Asthma phenotypes; Isoleucyl proline; Metabolomics; Methyl imidazoleacetic acid; Urocanic acid

Indexed keywords

BIOMOLECULES; BODY FLUIDS; DISEASES; METABOLISM; MULTIVARIANT ANALYSIS; PATHOLOGY;

ASTHMA PHENOTYPE; CHILDHOOD DISEASE; ISOLEUCYL-PROLINE; METABOLIC PROFILES; METABOLOMICS; METHYL-IMIDAZOLEACETIC ACID; PATHOGENIC MECHANISMS; SUB-GROUPS; URINE SAMPLE; UROCANIC ACID;

METABOLITES;

IMIDAZOLEACETIC ACID; UROCANIC ACID;

ALLERGIC ASTHMA; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EXCRETION; HUMAN; IMMUNITY; INFLAMMATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; MULTIVARIATE ANALYSIS; PHENOTYPE; PILOT STUDY; SCHOOL CHILD; URIC ACID URINE LEVEL; URINALYSIS;

EID: 83555172342     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1631     Document Type: Article

References (37)

1. Albert E, Walker J, Thiesen A, Churchill T and Madsen K. cis-Urocanic acid attenuates acute dextran sodium sulphate-induced intestinal inflammation. PLoS One 2010; 5: 13676-13685.
2. Bel EH. Clinical phenotypes of asthma. Current Opinion in Pulmonary Medicine 2004; 10: 44-50.
3. Bisgaard H and Szefler S. Prevalence of asthma-like symptoms in young children. Pediatric Pulmonology 2007; 42: 723-728.
4. Cakmak A, Zeyrek D, Atas A, Celik H, Aksoy N and Erel O. Serum prolidase activity and oxidative status in patients with bronchial asthma. Journal of Clinical Laboratory Analysis 2009; 23: 132-138.
5. Carraro S, Rezzi S, Reniero F, Héberger K, Giordano G, Zanconato S, Guillou C and Baraldi E. Metabolomics applied to exhaled breath condensate in childhood asthma. American Journal of Respiratory and Critical Care Medicine. 2007; 175: 986-990.
6. Chong IG and Jun CH. Performance of some variable selection methods when multicollinearity is present. Chemometrics and Intelligent Laboratory Systems 2005; 78: 103-112.
7. Djukanović R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH and Holgate ST. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. American Review of Respiratory Disease. 1992; 145: 669-674.
8. Enright P. The use and abuse of office spirometry. Primary Care Respiratory Journal 2008; 17: 238-242.
9. Frois C, Wu EQ, Ray S and Colice GL. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Clinical Therapeutics 2009; 31: 2779-2803.
10. Gibbs NK, Tye J and Norval M. Recent advances in urocanic acid photochemistry, photobiology and photoimmunology. Photochemical and Photobiological Sciences 2008; 7: 655-667.
11. GINA. Global strategy for asthma management and prevention, 2009. Available from (accessed 13 October 2009).
12. Gorman S, McGlade JP, Lambert MJ, Strickland DH, Thomas JA and Hart PH. UV exposure and protection against allergic airways disease. Photochemical and Photobiological Sciences 2010; 9: 571-577.
13. Guillarme D, Schappler J, Rudaz S and Veuthey JL. Coupling ultra-high pressure liquid chromatography with mass spectrometry. Trends in Analytical Chemistry 2010; 29: 15-27.
14. Hoekstra MO, Hovenga H, Gerritsen J and Kauffman HF. Eosinophils and eosinophil-derived proteins in children with moderate asthma. European Respiratory Journal 1996; 9: 2231-2235.
15. Holcapek M, Jirásko R and Lísa M. Basic rules for the interpretation of atmospheric pressure ionization mass spectra of small molecules. Journal of Chromatography A 2010; 1217: 3908-3921.
16. Killian KJ, Watson R, Otis J, St Amand TA and O'Byrne PM. Symptom perception during acute broncoconstriction. American Journal of Respiratory and Critical Care Medicine 2000; 162: 490-496.
17. Kind T and Fiehn O. Advances in structure elucidation of small molecules using mass spectrometry. Bioanalytical Reviews 2010; 2: 23-60.
18. Lange E, Tautenhahn R, Neumann S and Gröpl C. Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements. BMC Bioinformatics 2008; 9: 375-393.
19. Louhelainen N, Myllärniemi M, Rahman I and Kinnula VL. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. International Journal of Chronic Obstructive Pulmonary Disease 2008; 3: 585-603.
20. Mitchell RG, Thom H and Richardson JE. Histamine metabolism in asthma. Journal of Allergy and Clinical Immunology 1974; 54: 111-114.
21. Murdoch JR and Lloyd CM. Chronic inflammation and asthma. Mutation Research 2010; 690: 24-39.
22. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ and Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. Journal of Allergy and Clinical Immunology 2004; 113: 59-65.
23. Nordström A and Lewensohn R. Metabolomics: moving to the clinic. Journal of Neuroimmune Pharmacology 2010; 5: 4-17.
24. Ong PY. Emerging drugs for atopic dermatitis. Expert Opinion on Emerging Drugs 2009; 14: 165-179.
25. Pandher R, Ducruix C, Eccles SA and Raynaud FI. Cross-platform Q-TOF validation of global exo-metabolomic analysis: application to human glioblastoma cells treated with the standard PI 3-kinase inhibitor LY294002. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Science 2009; 877: 1352-1358.
26. Pavord ID, Brightling CE, Woltmann G and Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353: 2213-2214.
27. Piacentini GL, Bodini A, Costella S, Vicentini L, Mazzi P, Sperandio S and Boner AL. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. European Respiratory Journal 1999; 13: 1386-1390.
28. Sano H, Tada T, Moriyama A, Ogawa H, Asai K, Kawai Y, Hodgson ME, Kato T, Wada Y and Suchi M. Isolation of a rat histidase cDNA sequence and expression in Escherichia coli; evidence of extrahepatic/epidermal distribution. European Journal of Biochemistry 1997; 250: 212-221.
29. Saude EJ, Obiefuna IP, Somorjai RL, Ajamian F, Skappak C, Ahmad T, Dolenko BK, Sykes BD, Moqbel R and Adamko DJ. Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance. American Journal of Respiratory and Critical Care Medicine 2009; 179: 25-34.
30. Thurmond RL, Gelfand EW and Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nature Reviews Drug Discovery 2008; 7: 41-53.
31. Trygg J, Holmes E and Lundstedt T. Chemometrics in metabonomics. Journal of Proteome Research 2007; 6: 469-479.
32. Warrack BM, Hnatyshyn S, Ott KH, Reily MD, Sanders M, Zhang H and Drexler DM. Normalization strategies for metabonomic analysis of urine samples. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Science 2009; 877: 547-552.
33. Waters. Controlling contamination in ultraperformance LC/MS systems, 2005. Available from (accessed 12 May 2009).
34. Wiklund S, Johansson E, Sjöström L, Mellerowicz EJ, Edlund U, Shockcor PJ, Gottfries J, Moritz T and Trygg J. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Analytical Chemistry 2008; 80: 115-122.
35. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ and Forsythe I. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Research 2009; 37: 603-610.
36. Wolf S, Schmidt S, Müller-Hannemann M and Neumann S. In silico fragmentation for computer assisted identification of metabolite mass spectra. BMC Bioinformatics 2010; 11: 148-159.
37. Wong MC, Lee WT, Wong JS, Frost G and Lodge J. An approach towards method development for untargeted urinary metabolite profiling in metabonomic research using UPLC/QTOF MS. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Science 2008; 871: 341-348.